drugset / Trial / NCT05954052
A Study of Glutathione in Children With Autism Spectrum Disorder
NaSingle-groupOpen-labelOther
Summary
The aim of this study is to investigate if taking a supplement called Glutathione by mouth is safe and practical for children and teenagers with Autism Spectrum Disorder (ASD). The researchers plan to involve 24 individuals with ASD and give them oral Glutathione for 12 weeks.
Timeline
- Start
- 2019-07-01
- Primary completion
- 2023-08-15
- Completion
- 2023-08-15
Outcome
Missed primary endpoint
Stopped (Business): “lack of funding and difficulty with phlebotomy in children with Autism”
registry analysis (superiority test); Glutathione; p = 0.1807; Mean Difference (Final Values) 4 (95% CI -6.24 to 14.24); Wilcoxon (Mann-Whitney) NCT05954052 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glutathione | Peptide | 1000 mg | Oral |
| Subject | Glutathione | Peptide | 3000 mg | Oral |